Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Foster

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifsRobert J Young, Carl Adams, Mike Blows, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifsRobert J Young, Carl Adams, Mike Blows, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.
Pageof 5